Literature DB >> 1092511

Effect of tricyclic antidepressants and alcohol in psychomotor skills related to driving.

T Seppälä, M Linnoila, E Elonen, M J Mattila, M Mäki.   

Abstract

Twenty healthy subjects took amitriptyline, doxepin, and placebo for 2 wk each in a double-blind crossover trial, and another 20 subjects similarly took nortriptyline, chlorimipramine, and placebo. The antidepressants were given three times daily in doses generally used for neurotic patients. The presence of antidepressants in tissues was checked with the tyramine pressor test. On the seventh and fourteenth days of each period, psychomotor skills (choice reaction, coordination, and attention) were measured after the administration of drugs in combination with an alcoholic or placebo drink. Dose-response graphs for the tyramine pressor effect were shifted to the right during the antidepressant treatment, indicating a blockade of the membrane pump in peripheral sympathetic terminals. This antityramine effect of antidepressants did not correlate with their psychomotor effects. No drug alone importantly impaired psychomotor skills. Amitriptyline in combination with alcohol increased cumulative choice reaction times, and doxepin in combination with alcohol increased both cumulative choice reaction times and inaccuracy of reactions. Coordination was impaired after both of these combinations on the seventh day. It seems as if doxepin and amitriptyline but not nortiriptyline or chlorimipramine, in combination with 0.5 gm/kg of alcohol, may be especially dangerous in driving.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1092511     DOI: 10.1002/cpt1975175515

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  22 in total

1.  Effect of two weeks' treatment with thioridazine, chlorpromazine, sulpiride and bromazepam, alone or in combination with alcohol, on learning and memory in man.

Authors:  R Liljequist; M Linnoila; M J Mattila; I Saario; T Seppälä
Journal:  Psychopharmacologia       Date:  1975-10-31

Review 2.  Clinically significant drug interactions with antidepressants in the elderly.

Authors:  Edoardo Spina; Maria Gabriella Scordo
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 3.  Pharmacokinetic optimisation of tricyclic antidepressant therapy.

Authors:  M Furlanut; P Benetello; E Spina
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

4.  A comparative study of acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance.

Authors:  J G Ramaekers; N D Muntjewerff; J F O'Hanlon
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

Review 5.  Doxepin up-to-date: a review of its pharmacological properties and therapeutic efficacy with particular reference to depression.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-03       Impact factor: 9.546

6.  Alcohol and bupropion pharmacokinetics in healthy male volunteers.

Authors:  J Posner; A Bye; S Jeal; A W Peck; P Whiteman
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Evaluation and comparison of the interaction between alcohol and moclobemide or clomipramine in healthy subjects.

Authors:  I Berlin; A Cournot; R Zimmer; A M Pedarriosse; R Manfredi; P Molinier; A J Puech
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

8.  Effects of zimeldine, mianserin and amitriptyline on psychomotor skills and their interaction with ethanol a placebo controlled cross-over study.

Authors:  T Seppälä; C Strömberg; I Bergman
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Effects of amitriptyline and mianserin on psychomotor skills and memory in man.

Authors:  M J Mattila; R Liljequist; T Seppälä
Journal:  Br J Clin Pharmacol       Date:  1978       Impact factor: 4.335

10.  Interaction of alcohol with maprotiline or nomifensine: echocardiographic and psychometric effects.

Authors:  C Strömberg; A Suokas; T Seppälä
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.